MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report

NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) — MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the Company will release its second quarter 2024 financial results before the market opens on August 13, 2024. MiNK executives will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and to provide a corporate update.

Conference Call

Dial-in numbers: 646-307-1963 (New York), 800-715-9871 (USA & Canada)

Conference ID: 4021545

Webcast

A live webcast and replay of the conference call will be accessible from the Events & Presentations page of the Company’s website at https://investor.minktherapeutics.com/events-and-presentations and via https://edge.media-server.com/mmc/p/gwzqgg8t/.

About MiNK Therapeutics

MiNK Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery. The company is headquartered in New York, NY. For more information, visit https://minktherapeutics.com/ or @MiNK_iNKT. Information that may be important to investors will be routinely posted on our website and social media channels.

Investor Contact

917-362-1370

investor@minktherapeutics.com

Media Contact

781-674-4428

communications@minktherapeutics.com

Staff

Recent Posts

Aleen Inc. – 2025: A Year of Insight, Clarity, and Growth

Toronto, Ontario--(Newsfile Corp. - December 30, 2025) - Aleen Inc. (CSE: ALEN-U), a digital wellness…

5 minutes ago

CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones

TAMPA, FL / ACCESS Newswire / December 30, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH)…

2 hours ago

Amazfit Introduces Active Max: Bigger, Brighter, and Built for Maximum Performance

The newest member of the Active family blends new design, expanded storage, and longer battery…

5 hours ago

Pulse Urgent Care Notifies Individuals of Data Security Incident

REDDING, Calif., Dec. 29, 2025 /PRNewswire/ -- Docs Medical Group, Inc. dba Pulse Urgent Care…

8 hours ago

Interactive Strength Inc. (NASDAQ:TRNR) Provides Update on Sportstech Transaction

AUSTIN, TEXAS / ACCESS Newswire / December 29, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR"…

8 hours ago

In Spite of Trump’s Marijuana Executive Order, FDA Hemp and Marijuana Botanical Guidance Will Prevail

FDA Law-Not Hemp, Marijuana Politics-Will Decide the Future of Cannabinoid Medicine.Why "Full-Spectrum CBD" Narratives Are…

8 hours ago